论文部分内容阅读
血凝学实验诊断临床路径
【机 构】
：
北京大学人民医院
【出 处】
：
第6届中国医师协会全国检验与临床学术会议暨国际检验与临床高峰论坛
【发表日期】
：
2011年3期
其他文献
Carcinogenesis and Chemoprevention of Gallbladder Cancer with Pancreaticobiliary Maljunction or Chol
Pancreaticobiliary maljunction (PBM) or choledochal cyst is a high risk factor for biliary tract cancer especially in Asian people.In PBM, since the pancreatic duct and bile duct converge outside the
会议
Verotoxin-1 Treatment or Manipulation of its Receptor Gb3 for Reversal of Multidrug Resistance to Lu
A major problem with cisplatin treatment is the development of acquired-drug resistance of the tumour cells.Verotoxin1 (VT-1) exerts its cytotoxicity by targeting the membrane glycolipid globotriasosy
会议
Novel Mechanism of Herceptin Resistance in Breast Cancer-Signaling Network of ErbB2, ErbB3, and IGF-
Breast cancers with erbB2 alterations are more aggressive and typically more resistant to traditional therapeutic agents.Thus, the erbB2 receptor is an excellent target for breast cancer therapy.Herce
会议
Common Regulators for Hepatocellular Carcinoma Induced by Hepatitis B Virus X Antigen in a Mouse Mod
Hepatitis B virus (HBV) X antigen (HBx) plays an important role in the development of human hepatocellular carcinoma (HCC).We used an HBx transgenic mouse model to conduct genome-wide gene expression
会议
Finding Needles in a Haystack--Somatic Mutation Discovery in Lymphoma Using RNA-seq with Next-genera
Next-Generation Sequencing is being widely applied in many research areas such as genome assembly, gene mutaion discovery, epigenetics, SNP discovery, transcriptome (RNA-Seq) and gene expression analy
会议
Nanowires have been used to inject in a controlled way singlet oxygen into specific parts of a single cell.The new technique is based on growth of zinc oxide nanowires on a pipettee covered with a pho
会议
Current proteomic technologies are limited with respect to absolute quantification of protein levels and the amount of material required: large ensembles of cells are used.By working with population a
会议
TRAIL receptor agonists have been demonstrated as effective tumor therapeutics.Monoclonal antibodies against TRAIL receptor 1 or 2, such as Mapatumumab, Lexatumumab from Human Genome Sciences, Conatum
会议